Mikhail Blagosklonny is a talented scientist. He has stood out as an oncologist whose work is concerned with aging and cancer. Since he completed his education whereby he achieved great success, he has dedicated his time to conduct cancer research with the primary target being cancer therapies for the protection healthy body cells from being damaged.
The multi-talented scientist is also serving in other significant positions such as being an editor and assistant publisher of therapy as well as cancer biology. His primary focus is to make sure that all people that are suffering from cancer are well taken care of and can receive proper medication so as to continue leaving comfortably. Mikhail also serves as a board member that is concerned with editing cell death and differentiation.
As an author, he has written articles and books that are aimed at giving an explanation about his research and breakthrough. Blagosklonny is highly educated as Mikhail has a master’s degree in internal medicine. He obtained his degree from Pavlov State Medical University and a Ph.D. from the same institution. View Mikhail’s profile in LinkedIn
He has led a successful career since he started working. His first career breakthrough is when he was appointed the assistant professor of medicine ar the New York Medical College. Later, he became a scientist at Ordway research institution which is in Albany, New York.
He continued working hard and rose to become the professor of oncology at Roswell Park Cancer Institute where he still teaches. It is a position that has opened him to many opportunities from working with peers to working with his students. His students have been attracted to his work. Currently, he is doing research about drugs that can deal with anti-aging and cure cancer. He has an interest in discovering the mechanism behind aging and how to address the situation.
Mikhail Blagosklonny is always passionate about rapamycin which is a drug known that is known for curing cancer. He is the person behind the development of the hypothesis regarding the role of TOR as a signal for aging. He, therefore, came with rapamycin drug that is known to cure cancer and for life extension.
The main aim of the drug is to enable people who are aging to live longer. His research has been able to bear fruits because of his hard work and dedication. He is focused in the field of investigation and helping others to succeed in their discoveries. Visit ResearchGate.Net to learn more about Mikhail’s latest work.